The Neuroprotective Effects of DPP-4 and SGLT2 Inhibitors in Type 2 Diabetes: Possible Mechanism for Halting Cognitive Deterioration

被引：0
|
作者：
Osman, Shams T. [1 ]
Hamdy, Noha A. [1 ]
El Feky, Amr Y. [2 ]
El-Khordagui, Labiba K. [1 ]
El-Yazbi, Ahmed F. [3 ]
机构：
[1] Alexandria Univ, Fac Pharm, Alexandria, Egypt
[2] Alexandria Univ, Fac Med, Alexandria, Egypt
[3] Alexandria Univ, Alexandria, Egypt
来源：
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 2023年 / 385卷
关键词：
D O I：
10.1124/jpet.122.138010
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
256
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A Clinical Overview of DPP-4 Inhibitors for Type 2 Diabetes
    Jeon, Michelle
    Took, Roxane L.
    Peters, Golden L.
    US PHARMACIST, 2018, 43 (10) : 49 - 56
  • [32] The cardiovascular safety trials of DPP-4 inhibitors, GLP-1 agonists, and SGLT2 inhibitors
    Secrest, Matthew H.
    Udell, Jacob A.
    Filion, Kristian B.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2017, 27 (03) : 194 - 202
  • [33] Clinical Outcomes in Patients with Type 2 Diabetes Newly Initiating SGLT2 or DPP4 Inhibitors
    Adimadhyam, Sruthi
    Isaman, Danielle
    Weckstein, Andrew
    Payne, Emma
    Yu, Edward
    Louder, Anthony
    Reynolds, Shannon L.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 36 - 37
  • [34] Comparison between SGLT2 Inhibitors and DPP-4 Inhibitors Added to Insulin Therapy in Type 2 Diabetes: A Systematic Review with Indirect Comparison Meta-analysis
    Min, Se Hee
    Yoon, Jeong-Hwa
    Ahn, Chang Ho
    Kim, Lee-Kyung
    Moon, Sun Joon
    Ji, Myoung Jin
    Hahn, Seokyeong
    Cho, Young Min
    DIABETES, 2016, 65 : A64 - A64
  • [35] Comparing Effectiveness and Safety of SGLT2 Inhibitors vs DPP-4 Inhibitors in Patients With Type 2 Diabetes and Varying Baseline HbA1c Levels
    D'Andrea, Elvira
    Wexler, Deborah J.
    Kim, Seoyoung C.
    Paik, Julie M.
    Alt, Ethan
    Patorno, Elisabetta
    JAMA INTERNAL MEDICINE, 2023, 183 (03) : 242 - 254
  • [36] Relook at DPP-4 inhibitors in the era of SGLT-2 inhibitors
    Singh, Awadhesh Kumar
    Singh, Ritu
    WORLD JOURNAL OF DIABETES, 2022, 13 (06) : 466 - 470
  • [37] Inhibitors of SGLT2 and DPP-4 have similar risk of below-knee amputation
    Reactions Weekly, 2020, 1820 (1) : 9 - 9
  • [38] Pharmacokinetic Characteristics and Clinical Efficacy of an SGLT2 Inhibitor Plus DPP-4 Inhibitor Combination Therapy in Type 2 Diabetes
    André J. Scheen
    Clinical Pharmacokinetics, 2017, 56 : 703 - 718
  • [39] SGLT2 inhibitor/DPP-4 inhibitor combination therapy - complementary mechanisms of action for management of type 2 diabetes mellitus
    Dey, Jayant
    POSTGRADUATE MEDICINE, 2017, 129 (04) : 409 - 420
  • [40] The effects of SGLT2 inhibitors on corneal neuroinflammation in type 2 diabetes
    Asiedu, Kofi
    Tummanapalli, Shyam
    Alotaibi, Sultan
    Wang, Leiao Leon
    Dhanapalaratman, Roshan
    Kwai, Natalie
    Poynten, Ann
    Krishnan, Arun
    Markoulli, Maria
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
12345